Head-to-head · Cost-Efficiency Index
Tonik Wellness vs Kin Meds
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Tonik Wellness
Shoppers who want a named medical/clinical director and lab-work-first intake, and are willing to check stock before committing to the advertised price.
Visit Tonik WellnessKin Meds
Shoppers modeling the real monthly cost before they commit.
Visit Kin MedsThe verdict
Tonik Wellness takes it, leading the Cost-Efficiency Index 48 to 47. Tonik Wellness (Tonik Wellness LLC) prices compounded semaglutide and tirzepatide on identical Monthly/Quarterly/Annual ladders ($225/$165/$149 and $349/$249/$229), requires lab work before a provider consult. Kin Meds still earns a C — Shoppers modeling the real monthly cost before they commit.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Tonik Wellness.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Tonik Wellness | Kin Meds |
|---|---|---|
| Cost-Efficiency Index | 48/100 | 47/100 |
| Semaglutide / mo | $225/mo (annual plan, compounded) | Not disclosed |
| Tirzepatide / mo | $349/mo (annual plan, compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $2,700 | — |
| Tirzepatide / yr (modeled) | $4,188 | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #444 | #447 |
Tonik Wellness
48/100Where the value is
- Named, checkable clinical leadership: Medical Director Joel Jones, DO and Clinical Director Shawn Thurston, FNP
- Lab work is required as part of intake before the provider consult — more rigorous than an async questionnaire-only competitor
- LegitScript verification seal present in the footer
The tradeoffs
- Semaglutide's own product page showed 'This product is out of stock' at the time of this review, even though it is still actively priced and advertised on the marketing page
- No dedicated tirzepatide product page/SKU exists in site navigation, despite tirzepatide being fully priced on the weight-loss page
Kin Meds
47/100Where the value is
- Appears to have an established web/social presence per search results
The tradeoffs
- Site is unreachable for independent verification behind active bot/CAPTCHA protection
- No pricing, medical director, or pharmacy partner could be confirmed directly from the company
Regulatory note: the FDA issued a warning letter to Kin Meds in February 2026. We still list and link to Kin Meds; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.